Contact
Please use this form to send email to PR contact of this press release:
InspireMD Announces the Publication of an Investigator Initiated Clinical Registry Reaffirming MGuard(TM) Prime as a Highly Effective Tool to Prevent Heart Damage in Coronary Artery Blockages with High Thrombotic Content
TO: